Twenty years of hard work and a hundred years of road to start the journey again
Release time:
2020-08-14
二十年砥砺奋进 百年路再启征程
——浙江尖峰药业有限公司成立20周年回望
1998年12月31日,作为从水泥行业起家的上市公司尖峰集团跨行业发展的重要成果——浙江尖峰药业有限公司注册成立了。经过整整20年的艰苦创业和拼搏发展,截止目前,尖峰药业总资产达到14.93亿元,拥有下属全资、控股和参股药品生产企业7家、药品经营企业3家、国家级博士后科研工作站4家、省级院士专家工作站2家,拥有国际、国内药品发明专利52项,主导产品市场占有率排名前3。公司先后多次获评全国医药百强企业、浙江省医药工业十强企业、国家重点高新技术企业、国家知识产权示范企业,浙江省创新型示范企业、浙江省专利示范企业、浙江省“‘守合同,重信用’AAA企业”等系列荣誉,“尖峰”商标被认定为中国驰名商标。尖峰药业已经成为浙江省乃至全国有一定规模和影响力的综合性医药企业。
科技创新结硕果
新药开发是医药企业的龙头与生命。秉承“科技造就健康”的理念,从成立开始,尖峰药业便极为重视新药的开发工作,投入巨资与国内各大科研院所紧密合作,取得系列成果。
2000年3月,尖峰药业开发研制的第一只新药克拉霉素胶囊顺利获得生产批文,6月正式生产投放市场。
2000年12月,尖峰药业和中国药科大学联合研制开发的我国第一个沙星类国家一类新药加替沙星,获国家临床公告保护,保护期为12年,同时被列为省、市重大科技攻关项目。2003年1月,加替沙星正式投放市场,并被列入国家高技术产业化示范工程项目;2004年被授予“国家重点新产品”称号;2006年获得浙江省科技进步一等奖。
2002年8月,尖峰药业开发的国家级新药愈风宁心滴丸获准国内首家上市,填补了浙江省这一剂型的空白。
2002年10月,尖峰药业开发的心血管类抗高血压一线药物力斯得(门冬氨酸氨氯地平片)正式上市。
2004年5月,尖峰药业研制开发的第三代抗抑郁药舒坦罗(帕罗西汀)正式上市。
2004年8月,尖峰药业注射用盐酸头孢甲肟、甘油果糖注射液两个新药成功取得生产批文。10月,第三代半合成的头孢菌素类广谱抗生素——注射用盐酸头孢甲肟在国内首仿上市,长期占据了国内同类产品50%以上的市场份额。
2007年9月4日,尖峰药业研制开发的国内首家产品国家二类新药带状疱疹特效药——注射用喷昔洛韦获得国家药监局批准生产,并于2008年1月全球首家上市销售。
2009年2月,尖峰药业研制开发的又一国家级新药醋氯芬酸缓释片取得新药证书和生产批文,为国内独家剂型。
2017年3月,尖峰药业主持研发的国家一类新药注射用去氧鬼臼毒素取得临床试验批件,目前正由中国医学科学院肿瘤医院牵头,在全国各大医院开展临床试验。
……
在开发了众多新药、取得诸多科技创新成果的同时,尖峰药业公司和个人也取得了一系列荣誉。
尖峰药业于2002年8月被认定为金华市高新技术企业;2003年6月被认定浙江省高新技术企业;2007年10月通过国家火炬计划重点高新技术企业复审,成为国家级重点高新技术企业,此后连续四次通过高新技术企业认定;2011年9月获“浙江省创新型示范企业”称号、入围“中国医药工业企业百强”。集团董事长兼药业公司董事长蒋晓萌在2005年荣获国务院特殊津贴,2013年荣获“浙江省有突出贡献中青年专家”称号。集团副总经理、药业公司总经理黄金龙在2011年获 “浙江省优秀科技工作者”荣誉称号,2015年获“全国优秀科技工作者”荣誉称号。
在进行新药开发与科技创新的过程中,尖峰药业与相关高校、医药科研单位展开了广泛合作,成立了省级新药研究开发中心,与上海医药工业研究院、中国药科大学、四川抗菌素工业研究所、浙江工业大学、金华职业技术学院等单位建立了良好的合作关系,进行产学研的全面合作,并取得了双赢共利的可喜成果。
产能扩充壮实力
尖峰药业成立之初,是通过兼并收购临海制药厂、浙江金华生物化学制药厂,合资组建浙江迪耳江南分厂等进行药品生产的。在自主开发新药取得成果的同时,自建、扩建生产基地,增加企业产能和规模便提上日程。
2001年7月13日,尖峰药业秋滨制药基地项目破土动工,于2002年12月13日通过国家GMP认证,是当时华东地区最大的单体药厂。
2001年12月21日,尖峰药业江南制药厂综合制剂大楼扩建的三个车间、五种剂型通过国家GMP认证。
此后十多年的时间里,两个制药厂又历经了多次改、扩、建,仍不能满足尖峰药业日益增长的与销售相匹配的产能需求,新建一个全新的、更大规模的制造基地便提上了议事日程。
2012年7月31日,尖峰药业金西生产基地项目破土动工。经过近三年的建设,2015年6月,原江南厂全部搬迁完毕。6月15日,金西厂综合制剂车间开始投料生产。7月8日,首批产品醋氯芬酸缓释片离厂发货。从此,尖峰药业有了在浙江省乃至全国领先的、拥有一流制造设备和环境的、全新的大规模药品生产制造基地。
2018年8月3日,集团公司董事会又批准尖峰药业金西基地年产20亿片固体制剂项目投资计划,将面向欧盟和美国等国际市场出口药品,走向国际化发展道路。
随着尖峰药业制造规模和产能的扩大,很快确立了在医药行业的地位,早在2000年就被评为“浙江省十佳工业企业”和“浙江省医药工业十强企业”;2003年又名列“全国医药百强企业”;2008年名列全国医药企业总产值第34位;2010年和2011年,两度入选“中国医药工业百强企业”;2013年入选“中国医药行业十大最具成长力企业”……一个成熟的、高素质的现代医药企业迅速展现在世人面前,并在中国医药行业拥有了较高的知名度和影响力。
多元销售展新貌
产品营销关乎企业的生存。尖峰药业从成立开始,就有计划、有步骤地不断进行营销模式的整合,实现资源的优化配置,充分发挥各个企业的优势,从而扬长避短,协调发展,齐头并进。
从1998年注册成立,尖峰药业便下大力气组建自身工业产品的销售队伍,在全国各省市建立办事处,大力拓展药品代理和终端业务市场,销售规模、总额、利润不断上升。除此之外,像盐酸头孢甲肟、盐酸胺碘酮、吗替麦考等产品则采用了全国业务总代理的销售模式,也取得了相当不错的销售业绩。
1999年,金华市医药商业系统进行了有史以来最大的一次资产重组,尖峰药业公司联合尖峰集团以2208万元一次性买断金华市医药公司的全部资产。曾经是金华地区唯一的医药批发企业的金华市医药公司,从此成为尖峰药业的下属企业,专门从事医药商业批发业务。兼并整合之后,金华市医药公司以其全流通、高周转的业务模式,为尖峰药业迅速扩大整体销售规模、提升销售总额做出了重要贡献。
2001年,尖峰药业在原金华市医药公司下属零售药店的基础上注册成立尖峰大药房连锁有限公司,建立起以金华市区为中心,辐射周边县、市、乡镇的药品零售网络。自成立以来,尖峰大药房以其高质量、周到服务的零售模式迅速发展成为金华药品零售的领头企业之一,随着国家处方权的放开,将进一步发展壮大。这对扩大尖峰品牌影响、社会知名度起到了重要作用。
在多种销售齐头并进的良好格局之下,尖峰药业的销售规模迅速扩大。2008年名列中国化学制药工业协会医药工业企业产品销售收入排名第31位和利润总额排名第54位。2010年荣获由《医药观察家报》评选的“最具成就企业奖”。2016年和2018年两度荣获“最具品牌价值奖”。
联合兼并拓规模
尖峰药业从成立之初,便打破地域的限制,对外进行投资,借助外地的技术和人才资源,迅速扩大公司规模,提升公司技术水平。
1999年,尖峰药业在天津投资100万元组建成立高新技术企业——天津市尖峰天然产物研究开发公司,专业从事植物提取物的技术研究和产品开发,多项产品出口国际市场,现已成为国内植物提取物行业的领军企业,提取物联盟的理事长单位,主持制定了多项植物提取的技术标准,取得了良好的经济效益和社会效益。后来在天津又投资了天津尖峰弗兰德医药技术公司。
2016年,尖峰药业控股成立中德合资浙江金得尔儿婴药品有限公司(尔婴公司),以此为基础,引进德国技术和产品,进军婴幼儿药品市场。
2017年,尖峰药业与相关各方签订《关于北京慧宝源生物技术股份有限公司之增资和股份转让协议》,分四期投资,以北京慧宝源生物技术股份有限公司及其控股子公司广西慧宝源生物技术有限公司为平台,共同合作开展新药研发、药品生产经营等医药业务合作。
2018年1月,尖峰药业与相关各方签订了系列协议,通过收购股份和增效的方式对上海北卡医药技术有限公司进行投资,以上海北卡及其子公司为平台,建立原料药和中间体的研发、生产基地,进一步延伸并完善产业链,增加产业规模,提高研发能力,为尖峰药业原料药生产提供可靠保障。8月,集团公司董事会批准尖峰药业公司对上海北卡医药公司进行增资、尖峰药业下属上海北卡医药公司收购安徽众望制药公司两项投资计划,尖峰药业版图再次扩张。
通过近二十年的对外投资、兼并、整合,尖峰药业建立了一条从上游原料药到下游制剂产品的完整产业链,并借助外地大城市企业的技术和人才优势,建立了一个巨大的合作共赢的平台,为尖峰药业在深耕国内市场多年的基础上进军国际市场作好准备,为未来的长远发展打下了良好的基础。
知识产权管理显特色
作为从事医药产品制造与销售的企业,具有相对较高的技术含量,尖峰药业从一开始便注重对知识产权的保护与管理,积极参与商标、专利的申报。
2008年,尖峰药业“利欧”“立肖均”两只商标被认定为金华市著名商标。2012年,“尖峰”商标成为浙江省著名商标,2016年成为“中国驰名商标”。目前,尖峰药业拥有国内、国际药品发明专利52项,2013年被认定为浙江省专利示范企业。
2015年,尖峰药业专门召开《企业知识产权管理规范》贯标启动大会,全面加强知识产权管理工作。2016年,尖峰药业通过知识产权管理体系认证;2017年4月被评为国家知识产权优势企业,得分名列金华参评企业榜首;同年12月,又被确定为国家知识产权示范企业,为金华市本级企业首家,填补金华市本级空白。
通过这一系列的知识产权管理活动,取得了优异的成果,扩大了公司的品牌影响力和社会美誉度。
热心公益担责任
作为上市公司尖峰集团的子公司,尖峰药业一直热心社会公益事业,在全力做好公司自身的质量、安全、环保本职工作之外,多次参与公益行动并进行捐赠,切实承担起了企业的社会责任。
1999年,尖峰药业捐赠3万元支援西藏那曲地区医药事业;2002年,捐赠28台近百万的制药设备给新疆墨玉县以支援当地经济建设;2003年,捐赠价值28<
More information
On December 30, the group company held a special study meeting. Members of the group's party committee and management team concentrated on learning the spirit of the central economic work conference and the Zhejiang provincial party committee economic work conference. From December 16 to 18, the annual Central Economic Work Conference was held in Beijing, which made it clear that in 2021, "we should continue to implement a proactive fiscal policy and a prudent monetary policy, maintain the necessary support for economic recovery, be more accurate and effective in policy operation, do not make sharp turns, and grasp the effectiveness of the policy. It is necessary to make good use of the precious time window, concentrate on promoting reform and innovation, and take high-quality development as the general tone of the 14th five-year Plan. It is proposed to strengthen the national strategic scientific and technological strength, enhance the independent and controllable ability of the industrial chain supply chain, adhere to the strategic basis of expanding domestic demand, and comprehensively promote reform and opening up. On the 25th, the Zhejiang Provincial Party Committee Economic Work Conference was held in Hangzhou to make specific arrangements for the economic development of Zhejiang Province in 2021. At the study meeting, Jiang Xiaomeng, secretary of the party committee and chairman of the group company, together with the leaders attending the meeting, analyzed and studied the key issues raised at the economic work conference of the central and Zhejiang provincial party committees one by one. In his study and discussion, Jiang Xiaomeng stressed that the current neo-coronary pneumonia epidemic is still spreading around the world, the world economy is in a deep recession, the risk of strong stimulus policies in developed countries has spilled over, the global industrial chain supply chain cycle has been blocked, and international trade and investment have shrunk; major strategic achievements have been made in the prevention and control of the domestic epidemic, and the economy has recovered steadily, but there is still greater uncertainty of instability. China has turned to the stage of high-quality development, the economy has been improving for a long time, the development resilience is strong, and the overall social situation is stable. At the same time, the problem of unbalanced and inadequate development in China is still prominent, the reform task of key links in key areas is still arduous, and the innovation ability is not suitable; at present and in the future, China's development is still in an important period of strategic opportunities, but there are new development and changes in opportunities and challenges, we are accelerating the construction of a new development pattern with the domestic cycle as the main body and the domestic and international double cycle promoting each other. The economic work conference of the Central Committee and the Zhejiang provincial Party committee has set the tone and pointed the way for the future development of enterprises. Party organizations at all levels and enterprise management teams should seriously organize and study, deeply understand the spirit of the conference, correctly understand and judge the future policy direction and industry trend, scientifically plan the work of the new year in combination with the actual work of the enterprise, and promote the better development of the enterprise. (this newspaper reporter)
2021
01-04
A few days ago, Tianjin Jianfeng Flanders Company successfully passed the national high-tech enterprise re-identification review work, and once again joined the ranks of high-tech enterprises after the transformation of the enterprise. The original development orientation of Flanders is pharmaceutical excipients, which belongs to the biomedical industry supported by the state. Its products are mainly aimed at major pharmaceutical factories, with clear product standards and strong technical pertinence, so it has been recognized as a national high-tech enterprise for a long time. Starting from 2019, Flanders has embarked on an industrial transformation in the direction of healthy functional foods. The food industry has a variety of products and serves a wide range of people. Enterprises need to come up with products with unique value in order to be accepted and recognized by the market. The difficulty of identifying high-tech enterprises has also increased accordingly. In order to do a good job in the application evaluation of high-tech enterprises, Flanders, in addition to further combing the achievements of previous technological innovation, has also adjusted and established a high-level R & D team on the basis of establishing postdoctoral workstations in cooperation with Shenyang Pharmaceutical University and Tianjin University of traditional Chinese Medicine, and strengthened technological innovation and intellectual property protection in the direction of new industries. For more than a year, Flanders has successfully transformed, produced and put on the market a number of small molecule functional foods and special dietary products such as Huizhi Gold Drink. In order to further accelerate the pace of development in the health food industry, Flanders has successively joined the Tianjin Health Association, Tianjin Food Safety Association and other food industry organizations; and with the strong support of the Tianjin Association for Science and Technology, it began to prepare for the establishment of the Tianjin Medical and Health Society Health Industry Professional Committee. National high-tech enterprises identified once every three years. The person in charge of Flanders said that the company is currently in a critical period of development and transformation. The identification of high-tech enterprises is not only the recognition of the work of Flanders in the past two years by the competent authorities and the industry, but also will provide assistance to the future development of the company. In the future, Flanders will further increase its scientific research efforts, continue to develop and create new products with high-tech content, and make more contributions to public health. (Liu Hairong)
2020
12-22
On the afternoon of December 2, Sang Weiliang, secretary of the Qiandongnan Prefecture Party Committee of Guizhou Province, Wu Ming, deputy director of the Standing Committee of the State People's Congress, Long Zaichong, deputy secretary-general of the State Party Committee, and the main party and government leaders of Huangping County visited Huangping Jianfeng Cement Co., Ltd. to investigate and investigate, and preach the spirit of the Fifth Plenary Session of the 19th Central Committee of the Party. After visiting and understanding the company's production process, Sang Weiliang said happily: "I am very satisfied with the construction of a modern, clean and standardized cement production line in such a short period of time!" At the peak of Huang Ping, Sang Weiliang conveyed and preached the main contents of the spirit of the Fifth Plenary session of the 19th CPC Central Committee. He pointed out that governments at all levels in Qiandongnan Prefecture should thoroughly study and implement the spirit of the Fifth Plenary session of the 19th CPC Central Committee, earnestly implement the decisions and arrangements of the plenary session, focus on the main line of high-quality development, firmly grasp industrial projects, pay close attention to industrial economy, fully promote high-quality economic and social development, and strive to start a new journey of socialist modernization. We should persist in promoting the "four wheels" of new industrialization, we should pay close attention to the industrial economy, accelerate the transformation and upgrading of industrial industries, improve quality and efficiency, and strive to promote high-quality development and achieve stability and long-term development. During the investigation, Hu Hongwei, general manager of Huang Ping Jianfeng, introduced the basic situation of Jianfeng Group and Huang Ping Jianfeng to the state and county leaders, and focused on the equipment and process advantages of the production line, production process, production process, product quality control indicators, as well as various consumption indicators and emission indicators at the leading level in China. He also reported some problems and difficulties encountered after the formal operation of the enterprise. In view of the deficiencies in road traffic construction in Huangping County, Sang Weiliang asked the transportation department to strengthen communication, report and docking, strive for relevant support, do a solid job in the "14th Five-Year Plan" transportation development plan, further improve the road network connection and improve the transportation system, and provide strong support for the development of advantageous enterprises in Huangping Jianfeng and other regions. Sang Weiliang and his party also conducted in-depth research in the production workshop, checked the operation of the production line, and talked with the line staff. At the end of the investigation, he highly affirmed the construction and production work of Huang Ping Jianfeng for more than a year. The development of enterprises must take the road of sustainable development. It is necessary to ensure product quality and take into account the local ecology in order to develop in a long-term and sustainable manner. Sang Weiliang hopes that the Huangping County Government will do its best to ensure service, firmly establish a sense of service, and actively serve the enterprise. Serve, sincerely solve practical difficulties for the enterprise, create a good business environment, and help the enterprise achieve better development; also hope that Huang Ping Jianfeng will continue to play a pioneering role, jointly promote the high-quality economic and social development of Huangping County. (Pan Yi)
2020
12-22
Beirunning won the "13th Five-Year Chinese Medical Science and Technology Iconic Achievement" Award
From December 8 to 11, under the guidance of China Pharmacists Association, China over the counter drug Association and China Medical Education Association, the "2020 national pharmaceutical economic information conference and rice room annual meeting" sponsored by punctuation information (Group) was held in Guangzhou. During the event, the authoritative professional media of Chinese medicine, "Pharmaceutical Economics", released the list of "13th Five-Year China Pharmaceutical Science and Technology Iconic Achievements" and awarded the honorary certificate. The peak pharmaceutical product Berunning (Olopatadine Hydrochloride Eye Drops) is among them. Great changes have taken place in China's pharmaceutical industry during the 13th Five-Year Plan period. Drug review reform, consistency evaluation, volume procurement and other heavy policies in-depth promotion, driving the pharmaceutical industry innovation and upgrading. Chinese pharmaceutical leading enterprises take advantage of the trend, devote themselves to the development of new drugs, actively promote international registration, expand the international market, carry out international mergers and acquisitions, in the world life science stage blooming Chinese style. Lin Jianning, director of the Southern Institute of Pharmaceutical Economics of the State Drug Administration, combed the current operation of the pharmaceutical economy in detail and led the delegates to think deeply about the new changes in the pharmaceutical market in 2021. The industry authoritative media "Pharmaceutical Economic News" sponsored by the Southern Institute of Pharmaceutical Economics released the "13th Five-Year China Pharmaceutical Science and Technology Iconic Achievements" list during the event. The selection of this award aims to explore the scientific and technological achievements of China's pharmaceutical industry during the 13th five-year Plan period from the dimensions of scientific and technological innovation, clinical efficacy, market share and industry influence, so as to help transform pharmaceutical scientific and technological achievements. to help China move from a big pharmaceutical country to a pharmaceutical power. Pinnacle Pharmaceuticals' product, Berunning, is on the list. Berunning is the first eye drops to pass the consistency evaluation in China, and by virtue of its antagonistic histamine H1-receptor, stable mast cell two-way anti-allergy unique efficacy has been widely concerned. Beirunning in the treatment of children with allergic conjunctivitis has good effect, fast curative effect, will not cause significant mast cell degranulation, so the use of more safe, and almost no adverse reactions to the eye tissue, is the current treatment of allergic conjunctivitis an ideal drug. Since its launch in 2019, Berunning has received unanimous recognition and praise from domestic ophthalmologists. (Xu Yuting)
2020
12-22
On December 15, Xing Zhihong, deputy secretary of the Jinhua Municipal CPC Committee and acting mayor, accompanied by Cai Yan, secretary of the Wucheng District CPC Committee, Huang Guojun, and other leaders, visited the company for research, discussed and exchanged views with the company's management team, and put forward hope for the future development of Jianfeng as a leading enterprise in Jinhua City. Jiang Xiaomeng, chairman of the group company, introduced to Xing Zhihong and his party the development strategy, industrial layout, business performance in recent years, scientific and technological innovation, management innovation, as well as the work in charity, poverty alleviation and so on, which was fully affirmed by Xing Zhihong. Xing Zhihong said in the exchange that the peak is Jinhua's landmark enterprise and Jinhua's pride. It is not easy to stick to the industry for many years. Peak has a clear strategic direction and policy, and its good business performance in recent years has fully proved the courage and foresight of the management team. In view of the current situation that the pattern of economic competition at home and abroad is undergoing tremendous changes and the country's increasing requirements for environmental and ecological development, Xing Zhihong hopes that in the future work, Jianfeng will unswervingly follow the path of innovation and development, further increase investment in innovation and research and development, and further promote Green environmental protection production sets an example for Jinhua enterprises. He also hopes that the peak can "lay out the golden industry in the golden area", not only the enterprise itself through technological innovation to achieve high-quality development, but also further lead the upstream and downstream industries, attract potential and competitive enterprises to invest in Jinhua, forming a cluster effect. The municipal party committee and municipal government will also actively study and introduce better support policies to further optimize the business environment, so that enterprises can do a good job in production and operation without distractions, so that Jinhua can form a better industrial ecology. (this newspaper reporter)
2020
12-22